BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 12006528)

  • 1. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma.
    Tanaka K; Sonoo H; Kurebayashi J; Nomura T; Ohkubo S; Yamamoto Y; Yamamoto S
    Clin Cancer Res; 2002 May; 8(5):1125-31. PubMed ID: 12006528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance.
    Tang D; Nagano H; Yamamoto H; Wada H; Nakamura M; Kondo M; Ota H; Yoshioka S; Kato H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Wakasa K; Monden M
    Oncol Rep; 2006 Mar; 15(3):525-32. PubMed ID: 16465407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
    Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
    Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of thrombospondin-1 expression in relation to vascular endothelial growth factor and interleukin-10 expression at the deepest invasive tumor site of advanced colorectal carcinoma.
    Kaio E; Tanaka S; Oka S; Hiyama T; Kitadai Y; Haruma K; Chayama K
    Int J Oncol; 2003 Oct; 23(4):901-11. PubMed ID: 12963968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
    Eggert A; Ikegaki N; Kwiatkowski J; Zhao H; Brodeur GM; Himelstein BP
    Clin Cancer Res; 2000 May; 6(5):1900-8. PubMed ID: 10815914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma.
    Mitsuhashi N; Shimizu H; Ohtsuka M; Wakabayashi Y; Ito H; Kimura F; Yoshidome H; Kato A; Nukui Y; Miyazaki M
    Hepatology; 2003 May; 37(5):1105-13. PubMed ID: 12717391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases.
    Etoh T; Inoue H; Tanaka S; Barnard GF; Kitano S; Mori M
    Cancer Res; 2001 Mar; 61(5):2145-53. PubMed ID: 11280779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary carcinoma of the thyroid: evidence for a role for hepatocyte growth factor (HGF) in promoting tumour angiogenesis.
    Scarpino S; D'Alena FC; Di Napoli A; Ballarini F; Prat M; Ruco LP
    J Pathol; 2003 Feb; 199(2):243-50. PubMed ID: 12533838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer.
    Tokunaga T; Nakamura M; Oshika Y; Abe Y; Ozeki Y; Fukushima Y; Hatanaka H; Sadahiro S; Kijima H; Tsuchida T; Yamazaki H; Tamaoki N; Ueyama Y
    Br J Cancer; 1999 Jan; 79(2):354-9. PubMed ID: 9888480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
    Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M
    Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer.
    Lennard CM; Patel A; Wilson J; Reinhardt B; Tuman C; Fenton C; Blair E; Francis GL; Tuttle RM
    Surgery; 2001 May; 129(5):552-8. PubMed ID: 11331447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease.
    Fukuda S; Shirahama T; Imazono Y; Tsushima T; Ohmori H; Kayajima T; Take S; Nishiyama K; Yonezawa S; Akiba S; Akiyama S; Ohi Y
    Cancer; 1999 Mar; 85(6):1323-30. PubMed ID: 10189138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain.
    Péoch M; Farion R; Hiou A; Le Bas JF; Pasquier B; Rémy C
    Anticancer Res; 2002; 22(4):2147-51. PubMed ID: 12174896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
    Vajkoczy P; Farhadi M; Gaumann A; Heidenreich R; Erber R; Wunder A; Tonn JC; Menger MD; Breier G
    J Clin Invest; 2002 Mar; 109(6):777-85. PubMed ID: 11901186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of vascular endothelial growth factor (VEGF) in human thyroid tumors.
    Lewy-Trenda I; Wierzchniewska-Ławska A
    Pol J Pathol; 2002; 53(3):129-32. PubMed ID: 12476614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interrelated overexpression of endothelial and inducible nitric oxide synthases, endothelin-1 and angiogenic factors in human papillary thyroid carcinoma.
    Donckier JE; Michel L; Delos M; Havaux X; Van Beneden R
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):703-10. PubMed ID: 16712675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma.
    Kawahara N; Ono M; Taguchi K; Okamoto M; Shimada M; Takenaka K; Hayashi K; Mosher DF; Sugimachi K; Tsuneyoshi M; Kuwano M
    Hepatology; 1998 Dec; 28(6):1512-7. PubMed ID: 9828214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of vascular endothelial growth factor for thyroid neoplasms.
    Huang SM; Lee JC; Wu TJ; Chow NH
    World J Surg; 2001 Mar; 25(3):302-6. PubMed ID: 11343180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
    Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
    Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.